Dorsata, Inc.

Dorsata, Inc. is a technology company focused on delivering electronic health record (EHR) solutions specifically designed for women's healthcare practitioners, enhancing patient care through tailored clinical workflows and data collection capabilities. Founded in 2011 and headquartered in Arlington, US, Dorsata, Inc. specializes in electronic health record solutions for women's health care providers.

The company was established by David Fairbrothers, who is also the CEO. Dorsata raised USD 5. 2 mn in Series A funding on April 9, 2020, attracting investors like LabCorp Ventures and Motley Fool Ventures. The company has engaged in four total deals to date.

Dorsata specializes in electronic health record (EHR) solutions tailored specifically for women's health care providers, including obstetricians and gynecologists, life sciences organizations, and health plans. The company's core product offering is an advanced EHR platform designed to enhance obstetrics workflows and improve patient care. This platform integrates seamlessly into the clinical workflow, utilizing ACOG clinical guidelines and a sophisticated rules-based engine to facilitate diagnosis, treatment, and documentation at the point of care. Dorsata’s solutions are in use across over 300 women's health practice sites in 20 states, serving a substantial client base of more than 2,500 clinical users and impacting approximately 1.

5 million patients annually. The company addresses critical gaps in clinical data for pregnant patients, who are frequently excluded from clinical trials, by enabling the collection of real-world clinical data through its Dorsata Insights product. Dorsata generates revenue primarily through subscription-based models for its EHR solutions, which cater to women's health providers. Clients pay for access to Dorsata's platform based on their specific practice needs and the scale of their operations.

The business model may involve partnerships with health plans and life sciences organizations to enhance the utility of its clinical data. The structure of transactions typically revolves around B2B relationships, where hospitals and health care practices subscribe to Dorsata's services to improve their operational efficiency and patient care outcomes. This enables Dorsata to maintain a steady revenue stream while ensuring that their clients can access critical clinical data and support tailored to the needs of women's health care. Following its recent Series A funding of USD 5.

2 mn, Dorsata, Inc. aims to further develop its EHR platform with new features tailored for women's health practitioners. The company is exploring expansion into additional geographic markets with plans to target specific regions within the US by 2022. The funding will be utilized to enhance product development and support market entry initiatives.